Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock
ANDROMEDA-SHOCK-2 trial design and results
Design
Multicentre randomised clinical trial with a hierarchical composite endpoint
Treatment
Personalised haemodynamic resuscitation targeting capillary refill time
Control
Usual care
Population
1467 patients analysed with early septic shock, mean age 66, 43.3% female
Follow-up
28 days
Primary endpoint
Hierarchical composite analysed by win ratio
Result
There were 131,131 wins (48.9%) in the capillary refill time group versus 112,787 (42.1%) in the usual care group for the hierarchical composite.
Secondary endpoints
Mortality, organ dysfunction, resuscitation intensity
Among patients with early septic shock, a personalized hemodynamic resuscitation protocol targeting capillary refill time was superior to usual care for the primary composite outcome, primarily due to a lower duration of vital support.
The trial authors, in the published abstract
How it has aged
After two decades of failed protocols (Rivers EGDT and its three replications), a target that requires nothing more than a finger and a stopwatch outperforms usual care. Win-ratio composites are hard to interpret clinically, so the practical size of the benefit is less clear than its direction.
Publications
Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial
Hernandez G, Ospina-Tascón GA, Kattan E, et al. Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial. JAMA 2025 Dec 9;334(22):1988-1999.
48.9% wins versus 42.1% on the hierarchical composite